Education
About Us
Working with TipRanks
Follow Us
Twist Bioscience Corp (TWST)
NASDAQ:TWST
Total Valuation
Twist Bioscience has a market cap or net worth of $1.55B. The enterprise value is $2.08B.
Market Cap$1.55B
Enterprise Value$2.08B
Share Statistics
Twist Bioscience has 60,360,924 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding60,360,924
Owned by Insiders2.55%
Owned by Institutions0.02%
Financial Efficiency
Twist Bioscience’s return on equity (ROE) is -0.44 and return on invested capital (ROIC) is -39.67%.
Return on Equity (ROE)-0.44
Return on Assets (ROA)-0.34
Return on Invested Capital (ROIC)-39.67%
Return on Capital Employed (ROCE)-0.41
Revenue Per Employee339.08K
Profits Per Employee-226.14K
Employee Count923
Asset Turnover0.51
Inventory Turnover7.46
Valuation Ratios
The current PE Ratio of Twist Bioscience is ―. Twist Bioscience’s PEG ratio is 0.00.
PE Ratio―
PS Ratio8.38
PB Ratio5.55
Price to Fair Value5.55
Price to FCF-37.89
Price to Operating Cash Flow-32.29
PEG Ratio0.00
Income Statement
In the last 12 months, Twist Bioscience had revenue of 312.97M and earned -208.73M in profits. Earnings per share was -3.60.
Revenue312.97M
Gross Profit133.35M
Operating Income-220.83M
Pretax Income-208.17M
Net Income-208.73M
EBITDA-176.71M
Earnings Per Share (EPS)-3.60
Cash Flow
In the last 12 months, operating cash flow was -51.13M and capital expenditures -17.58M, giving a free cash flow of -68.71M billion.
Operating Cash Flow-51.13M
Free Cash Flow-68.71M
Free Cash Flow per Share-1.14
Dividends & Yields
Twist Bioscience pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.53
52-Week Price Change-39.97%
50-Day Moving Average34.15
200-Day Moving Average40.44
Relative Strength Index (RSI)25.39
Average Volume (3m)1.21M
Important Dates
Twist Bioscience upcoming earnings date is Nov 24, 2025, After Close (Confirmed).
Last Earnings DateAug 4, 2025
Next Earnings DateNov 24, 2025
Ex-Dividend Date―
Financial Position
Twist Bioscience as a current ratio of 4.88, with Debt / Equity ratio of 16.34%
Current Ratio4.88
Quick Ratio4.54
Debt to Market Cap0.00
Net Debt to EBITDA0.80
Interest Coverage Ratio-7.61K
Taxes
In the past 12 months, Twist Bioscience has paid 560.00K in taxes.
Income Tax560.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Twist Bioscience EV to EBITDA ratio is -14.03, with an EV/FCF ratio of -35.85.
EV to Sales7.92
EV to EBITDA-14.03
EV to Free Cash Flow-35.85
EV to Operating Cash Flow-38.69
Balance Sheet
Twist Bioscience has $250.80M in cash and marketable securities with $78.15M in debt, giving a net cash position of -$172.65M billion.
Cash & Marketable Securities$250.80M
Total Debt$78.15M
Net Cash-$172.65M
Net Cash Per Share-$2.86
Tangible Book Value Per Share$6.42
Margins
Gross margin is 30.93%, with operating margin of -70.56%, and net profit margin of -66.69%.
Gross Margin30.93%
Operating Margin-70.56%
Pretax Margin-66.51%
Net Profit Margin-66.69%
EBITDA Margin-56.46%
EBIT Margin-66.50%
Analyst Forecast
The average price target for Twist Bioscience is $37.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$37.50
Price Target Upside46.26% Upside
Analyst ConsensusModerate Buy
Analyst Count7
Revenue Growth Forecast22.72%
EPS Growth Forecast62.11%